Oncology

New breast cancer research out of Johns Hopkins' Sidney Kimmel Comprehensive Cancer Center reveals the cellular, microbial and genomic makeup of cancerous breast tumors differ greatly between white, Black and Asian women. This information "could potentially be used to personalize…

When the FDA updated the 1992 Mammography Quality Standards Act to require patients be informed directly if they have dense breasts, the move may have opened a "Pandora's box," Elisa Port, MD, chief of breast surgery at New York City-based…

Plainsboro, N.J.-based Penn Medicine Princeton Cancer Center received $2.5 million to fund its geriatric oncology program.

The FDA issued draft guidance for clinical trials of oncology drugs in the accelerated approval application.

A recent study found that adding gemcitabine antibiotics with chemotherapy can improve survival rates by 11 percent for patients with a subset of pancreatic cancer.

Seattle-based Fred Hutchinson Cancer Center is set to open its $320 million, 150,000-square foot clinic building.

Boston-based Dana-Farber Cancer Institute researchers found a way to reduce cancer diagnosis time from 32 days to 12 for underserved populations, The ASCO Post reported March 22.

A recent study found progestogen-only contraceptives have a similar risk of breast cancer as combined hormone options, NBC News reported March 21.

Philadelphia-based Fox Chase Cancer Center is trying a less invasive treatment for prostate cancer that does not necessitate removal of the organ, CBS Philadelphia reported March 21.

The COVID-19 pandemic brought on a tidal wave of challenges across all healthcare systems. And cancer hospitals and oncology departments had to manage not only those rapidly increasing concerns but also the critical timeliness associated with managing cancer patients.